T.Man Pharmaceutical PCL (BKK:TMAN)

Market Cap	4.92B
Revenue (ttm)	2.23B
Net Income (ttm)	450.70M
Shares Out	400.00M
EPS (ttm)	1.31
PE Ratio	9.37
Forward PE	9.18
Dividend	n/a
Ex-Dividend Date	n/a

Volume	488,283
Average Volume	771,783
Open	12.50
Previous Close	12.40
Day's Range	12.10 - 12.60
52-Week Range	11.70 - 19.30
Beta	n/a
RSI	38.47
Earnings Date	Apr 4, 2025

About T.Man Pharmaceutical PCL

T.Man Pharmaceutical Public Company Limited manufactures and sells pharmaceuticals and health products. It offers a range of pharmaceutical products, including antibiotics, gastrointestinal drugs, respiratory drugs, musculoskeletal drugs, nervous system drugs, and chronic disease drugs, as well as medicines for the skin in form of tablets, capsules, powders, liquids, and semisolids. The company was incorporated in 2023 and is headquartered in Bangkok, Thailand.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2023
• Employees: 944
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: TMAN

Financial Performance

In 2024, T.Man Pharmaceutical PCL's revenue was 2.23 billion, an increase of 12.42% compared to the previous year's 1.98 billion. Earnings were 450.70 million, an increase of 4.55%.